Sponsor Pipeline

4D Molecular Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
4
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1/2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07064759 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization… Neovascular Age-Related Macular Degeneration (nAMD) Recruiting
NCT06864988 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular… Macular Neovascularization Secondary to Age-Related Macular Degeneration Active, Not Recruiting
Phase 2
NCT05248230 4D-710 in Adult Patients With Cystic Fibrosis Cystic Fibrosis Lung Recruiting
NCT05930561 4D-150 in Patients With Diabetic Macular Edema Diabetic Macular Edema Active, Not Recruiting
Phase 1/2
NCT05629559 4D-310 in Adults With Fabry Disease and Cardiac Involvement Fabry Disease Recruiting
NCT05197270 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration Neovascular (Wet) Age-Related Macular Degeneration Recruiting
NCT04519749 An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease Fabry Disease Active, Not Recruiting
NCT04517149 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) X-Linked Retinitis Pigmentosa Active, Not Recruiting
Phase 1
NCT04483440 Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia Choroideremia Active, Not Recruiting
Disease Areas
Get alerts when 4D Molecular Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free